| Source: |
| Type: |
| Destruction of mitochondrial transmembrane potential, which is widely regarded as one of the earliest events in the process of cell apoptosis. Mitochondria are organelles within eukaryotic cells that produce adenosine triphosphate (ATP), the main energy molecule used by the cell. For this reason, the mitochondrion is sometimes referred to as “the powerhouse of the cell”. Mitochondria produce ATP through process of cellular respiration—specifically, aerobic respiration, which requires oxygen. The citric acid cycle, or Krebs cycle, takes place in the mitochondria. The mitochondrial membrane potential is widely used in assessing mitochondrial function as it relates to the mitochondrial capacity of ATP generation by oxidative phosphorylation. The mitochondrial membrane potential is a reliable indicator of mitochondrial health. In cancer cells, ΔΨm is often decreased, which can lead to changes in cellular metabolism, increased glycolysis, increased reactive oxygen species (ROS) production, and altered cell death pathways. The membrane of malignant mitochondria is hyperpolarized (−220 mV) in comparison to their healthy counterparts (−160 mV), which facilitates the penetration of positively charged molecules to the cancer cells mitochondria. The MMP is a critical indicator of mitochondrial function, directly reflecting the organelle's capacity to generate ATP through oxidative phosphorylation. |
| 1899- | MeJa, | Methyl jasmonate induces production of reactive oxygen species and alterations in mitochondrial dynamics that precede photosynthetic dysfunction and subsequent cell death |
| - | in-vitro, | Var, | NA |
| 8759- | MeSA, | Methylseleninic acid induces apoptosis of human bladder cancer cells through the ROS-mediated mitochondrial pathway |
| - | in-vitro, | Bladder, | J82 | - | in-vitro, | CRC, | T24/HTB-9 |
| 2457- | MET, | Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II |
| - | in-vitro, | Lung, | Calu-1 |
| 5795- | MET, | Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Diabetic, | NA |
| 2242- | MF, | Electromagnetic stimulation increases mitochondrial function in osteogenic cells and promotes bone fracture repair |
| - | in-vitro, | Nor, | NA |
| 8483- | MF, | Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies |
| - | Review, | Var, | NA |
| 8486- | MF, | Silent forces, hidden currents: the influence of static magnetic field stimulation on tumor biophysics |
| - | Review, | Var, | NA |
| 4147- | MF, | PEMFs Restore Mitochondrial and CREB/BDNF Signaling in Oxidatively Stressed PC12 Cells Targeting Neurodegeneration |
| - | in-vitro, | AD, | PC12 |
| 525- | MF, | Pulsed electromagnetic fields regulate metabolic reprogramming and mitochondrial fission in endothelial cells for angiogenesis |
| - | in-vitro, | Nor, | HUVECs |
| 532- | MF, | A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
| 538- | MF, | The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Melanoma, | MSTO-211H |
| 507- | MF, | Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | GP-293 |
| 520- | MF, | Exposure to a 50-Hz magnetic field induced mitochondrial permeability transition through the ROS/GSK-3β signaling pathway |
| - | in-vitro, | Nor, | NA |
| 4568- | MF, | Extremely low-frequency pulses of faint magnetic field induce mitophagy to rejuvenate mitochondria |
| - | Study, | Var, | NA |
| 9267- | MFrot, | EXTH-12. Oncomagnetic Monotherapy Mediated Anti-Tumor Immune Response in Glioblastoma |
| - | Review, | GBM, | NA |
| 2259- | MFrot, | MF, | Method and apparatus for oncomagnetic treatment |
| - | in-vitro, | GBM, | NA |
| 3493- | MFrot, | MF, | Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes |
| - | in-vivo, | GBM, | NA |
| 186- | MFrot, | MF, | Selective induction of rapid cytotoxic effect in glioblastoma cells by oscillating magnetic fields |
| - | in-vitro, | GBM, | GBM | - | in-vitro, | Lung, | NA |
| 184- | MFrot, | MF, | Rotating Magnetic Fields Inhibit Mitochondrial Respiration, Promote Oxidative Stress and Produce Loss of Mitochondrial Integrity in Cancer Cells |
| - | in-vitro, | GBM, | GBM |
| 198- | MFrot, | MF, | Biological effects of rotating magnetic field: A review from 1969 to 2021 |
| - | Review, | Var, | NA |
| 9154- | MG, MIC-1, | Moringin, an isothiocyanate modulates multiple cellular signalling molecules in breast cancer cells |
| - | in-vitro, | BC, | NA |
| 9073- | MGF, | Mangiferin induces apoptosis in multiple myeloma cell lines by suppressing the activation of nuclear factor kappa B-inducing kinase |
| - | in-vitro, | MM, | NA |
| 9087- | MGF, | Mangiferin in human disease: Multifaceted mechanisms and applications (Review) |
| - | Review, | Var, | NA |
| 1891- | MGO, | Methylglyoxal induces mitochondria-dependent apoptosis in sarcoma |
| - | in-vitro, | SCC, | NA |
| 6418- | MLT, | RES, | Melatonin improves mitochondrial function by preventing mitochondrial fission in cadmium-induced rat proximal tubular cell injury via SIRT1-PGC-1α pathway activation |
| - | in-vivo, | AD, | NA |
| 8658- | MLT, | Melatonin drives apoptosis in head and neck cancer by increasing mitochondrial ROS generated via reverse electron transport |
| - | vitro+vivo, | SCC, | CAL27 | - | in-vitro, | Tong, | SCC9 |
| 8663- | MLT, | Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect |
| - | vitro+vivo, | RCC, | 786-O |
| 8689- | MLT, | Role of melatonin in Alzheimer's disease: From preclinical studies to novel melatonin-based therapies |
| - | Review, | AD, | NA |
| 8685- | MLT, | Melatonin acts synergistically with pazopanib against renal cell carcinoma cells through p38 mitogen-activated protein kinase-mediated mitochondrial and autophagic apoptosis |
| - | vitro+vivo, | RCC, | 786-O |
| 8679- | MLT, | Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis |
| - | in-vitro, | Pca, | NA |
| 3839- | MO, | Nutritional Value of Moringa oleifera Lam. Leaf Powder Extracts and Their Neuroprotective Effects via Antioxidative and Mitochondrial Regulation |
| - | in-vitro, | AD, | NA |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | A2058 |
| 8910- | MO, | Moringa oleifera L. leaf extract induces cell cycle arrest and mitochondrial apoptosis in Dalton's Lymphoma: An in vitro and in vivo study |
| - | vitro+vivo, | lymphoma, | NA |
| 8897- | MOR, | Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
| 8874- | MOR, | The anticarcinogenic and anticancer effects of the dietary flavonoid, morin: Current status, challenges, and future perspectives |
| - | Review, | Var, | NA |
| 8871- | MOR, | MGF, | Mangiferin and Morin Attenuate Oxidative Stress, Mitochondrial Dysfunction, and Neurocytotoxicity, Induced by Amyloid Beta Oligomers |
| - | in-vitro, | AD, | NA |
| 8868- | MOR, | PacT, | Synergistic effect of morin and paclitaxel impedes cell proliferation through PI3K/AKT/STAT3 signaling axis inhibition in gastric cancer |
| - | in-vitro, | GC, | HGC27 |
| 8863- | MOR, | Morin Inhibits Proliferation of SW480 Colorectal Cancer Cells by Inducing Apoptosis Mediated by Reactive Oxygen Species Formation and Uncoupling of Warburg Effect |
| - | in-vitro, | Colon, | SW48 |
| 8862- | MOR, | The flavonoid morin from Moraceae induces apoptosis by modulation of Bcl-2 family members and Fas receptor in HCT 116 cells |
| - | in-vitro, | CRC, | HCT116 |
| 8880- | MOR, | Morin, a Natural Flavonoid, Activates the PINK1/Parkin Pathway to Induce Mitophagy, Promote Apoptosis, and Suppress Cancer Stemness in Pancreatic Cancer |
| - | in-vitro, | PC, | NA |
| 8878- | MOR, | Investigating the Effects of Morin and Aminoimidazole Carboxamide Ribonucleotide on the AMPK/mTOR/ULK1 Signaling Pathway in Breast Cancer Cell Line (MCF-7) |
| - | in-vitro, | BC, | MCF7 |
| 8780- | MSM, | Methylsulfonylmethane Induces Cell Cycle Arrest and Apoptosis, and Suppresses the Stemness Potential of HT-29 Cells |
| - | in-vitro, | CRC, | HT-29 |
| 8779- | MSM, | Effect of Methylsulfonylmethane on Proliferation and Apoptosis of A549 Lung Cancer Cells Through G2/M Cell-cycle Arrest and Intrinsic Cell Death Pathway |
| - | in-vitro, | Lung, | A549 |
| 8936- | MushCha, | Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis |
| - | vitro+vivo, | Lung, | LLC1 |
| 1170- | MushCha, | Chaga mushroom extract suppresses oral cancer cell growth via inhibition of energy metabolism |
| - | in-vitro, | Oral, | HSC4 |
| 8968- | mushLions, | Mechanism of Hericium erinaceus (Yamabushitake) mushroom-induced apoptosis of U937 human monocytic leukemia cells |
| - | in-vitro, | lymphoma, | U937 |
| 8953- | mushLions, | Fruiting body polysaccharides of Hericium erinaceus induce apoptosis in human colorectal cancer cells via ROS generation mediating caspase-9-dependent signaling pathways |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | DLD1 |
| 9302- | MushMait, | Black Maitake mushroom (Grifola frondosa) extract exerts anti-cancer effects and enhances the efficacy of chemotherapeutic drugs in 2D and 3D models of triple-negative breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 |
| 5609- | NaHCO3, | Alkalization of cellular pH leads to cancer cell death by disrupting autophagy and mitochondrial function |
| - | in-vitro, | Var, | NA |
| 6490- | Nimb, | Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer |
| - | in-vitro, | Oral, | SCC4 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:197 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid